UKHSA seeks market info on oligonucleotide manufacturing for onshoring.
The UK Health Security Agency (UKHSA) is issuing a Request for Information (RFI) to understand the marketplace for oligonucleotide manufacturing, with a focus on onshoring capability to improve UK biosecurity and resilience for infectious diseases. Oligonucleotides are essential reagents for molecular diagnostics, sequencing, serological assays, and development of vaccines and therapeutics. UKHSA seeks to understand current manufacturing capacity, dependencies, bottlenecks, and future intentions for UK-based production. This RFI is not a sourcing exercise; responses will inform future procurement strategy. Respondents must complete a questionnaire via the provided link.